“…However, some of the contrast agents are visible on both T 1 - and T 2 -weighted images, which grasp more attention due to functioning as dual-mode contrast agents in MRI. , For instance, manganese (Mn 2+ )-doped silica nanoparticles, , Mn-doped nanoparticles, Mn-doped sulfide quantum dots, and (Mn)–ND conjugates have demonstrated the dual mode contrast enhancement in MRI imaging due to Mn’s characteristic property of displaying the T 1 – T 2 dual-mode contrast ability. , However, Mn has an adverse effect on biocompatibility due to its toxicity on cardiotoxicity and neurodegenerative effects. , Even though Mn chelates and conjugates were utilized as MRI contrast agents due to their low toxicity and desired relaxivity. ,, In addition, according to our best knowledge, very few studies have been reported on Mn-ND-based MRI contrast agents, especially one study that reported ND-Mn dual-mode contrast enhancement for liver tumor detection . In addition, the Mn chelates or conjugates are prepared by chemical methods and have the probability of leaching during MRI imaging and causing the related toxicity.…”